MR-Evaluation of Renal Function-After-Pancreas-transplantation (MERFAP)
|ClinicalTrials.gov Identifier: NCT01537445|
Recruitment Status : Unknown
Verified February 2012 by Per Liss, Uppsala University.
Recruitment status was: Not yet recruiting
First Posted : February 23, 2012
Last Update Posted : February 23, 2012
|Condition or disease|
|Diabetes Renal Failure Pancreas Transplantation|
|Study Type :||Observational|
|Estimated Enrollment :||40 participants|
|Official Title:||MR-Evaluation of Renal Function-After-Pancreas-transplantation|
|Study Start Date :||February 2012|
|Estimated Primary Completion Date :||February 2015|
|Estimated Study Completion Date :||August 2015|
Patients with pancreastransplantation
All patients undergoing pancreas transplantation.
- Kidney function [ Time Frame: Within 3 years ]Improvements in kidney function (GFR) and proteinuria after pancreas transplantation.
- Kidney hemodynamics and oxygenation [ Time Frame: Within 3 years ]Improvements in renal blood flow and kidney tissue oxygenation after pancreas transplantation.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01537445
|University Hospital||Not yet recruiting|
|Uppsala, Sweden, 75185|
|Contact: Per Liss, MD, PhD. +46186110000 firstname.lastname@example.org|
|Study Director:||Per Liss, MD, PhD.||Uppsala University, Uppsala, Sweden|